Mirabegron Efficacy Compared to Antimuscarinics over 12 weeks (178-CL-046) Mean reduction in OAB symptoms compared to placebo Incontinence episodes/ 2
{"Image DocumentName": "Mean reduction in OAB symptoms compared to placebo", "Image ImageDescription": "Mirabegron Efficacy Compared to Antimuscarinics over 12 weeks (178-CL-046) Mean reduction in OAB symptoms compared to placebo. Incontinence episodes/ 24hrs. Micturitions/ 24hrs. Urgency episodes (Grade 3/4)/24hrs. \u2020   \u2020    \u2020\u2020     Mirabegron demonstrated significant improvements in OAB symptoms, including urgency.  p=0.003 vs. placebo;   p<0.001 vs. placebo;    p=0.005 vs. placebo; \u2020 p=0.11(NS) vs. placebo; \u2020 \u2020p=0.05 vs. placebo. Mirabegron Product Monograph, 2013; Khullar V et al. Eur Urol. 2013;63:283\u2013295.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}